OLYSIO

Peak

simeprevir sodium

Johnson & Johnson
NDAORALCAPSULEPriority Review
Approved
Nov 2013
Lifecycle
Peak
Competitive Pressure
8/100

Loss of Exclusivity

LOE Date
Sep 5, 2029
42 months away
Patent Expiry
Sep 5, 2029

Patent Records (5)

Patent #ExpiryTypeUse Code
9856265
Jul 28, 2026
SubstanceProduct
U-1467
8349869
Jul 28, 2026
SubstanceProduct
U-1467
8741926
Jul 28, 2026
Substance
U-1467
8754106
Jul 28, 2026
Substance
U-1467
9040562
Jul 28, 2026
SubstanceProduct
U-1467
Company
J&
Johnson & Johnson
NEW BRUNSWICK, NJ
1798 open jobs
External Resources
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers